ARCHIVES

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

This article is from The Cancer Letter archive.

Vol. 26 No. 10 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

Cancer Centers Branch To Be ‘More Proactive,’ Kimes Tells NCAB

January 12, 1990

NCI Appropriations Still Hung Up

September 30, 1977

Statins May Not Have Impact On Testosterone In The Blood

August 31, 2007

Cancer Accounts for 23% of U.S. Deaths, American Cancer Society Says.

January 21, 2005

NCI Lung Cancer Mutation Consortium: Screening For Mutations Can Focus Therapy

June 24, 2011

Consolidation Unlikely to Save Money

December 17, 2010